Abiopharma

🔍 HUTCHINS GLENN H (Director)

Company: CoreWeave, Inc. (CRWV)

Report Date: 2026-08-10

Detailed Transactions and Holdings:

• Acquired 1,440 shares of Class A Common Stock (Direct)
  Date: 2026-08-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 11,323.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-08-10 | Code: H | nature_of_ownership: North Island Inferno Fund II LLC | shares_owned_after: 10,640.00 | Footnotes: F2
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-08-10 | Code: H | nature_of_ownership: Tide Mill LLC | shares_owned_after: 384,840.00 | Footnotes: F3
• Sold 1,440 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 8,680.00 | transaction_form_type: 4 | Footnotes: F1, F1, F4, F5

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.
• F2: The reported securities are directly held by North Island Inferno Fund II LLC ("North Island Inferno"). The reporting person serves as investment manager for North Island Inferno and as such may be deemed to exercise shared voting and investment discretion over securities held by it. The reporting person disclaims beneficial ownership for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Exchange Act"), except to the extent of his pecuniary interest therein, if any.
• F3: The reported securities are directly held by Tide Mill LLC ("Tide Mill"). The managing member of Tide Mill is North Island Management, LLC ("NIM"). The reporting person serves as chairman of NIM and may be deemed to directly or indirectly exercise voting and investment discretion over the investments of NIM and Tide Mill. The reporting person disclaims beneficial ownership for purposes of Section 16 of the Exchange Act except to the extent of his pecuniary interest therein, if any.
• F4: The award vested or vests as to 1/12 of the total award on the tenth calendar day of May, August, November, and February, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vested on May 10, 2025.
• F5: These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.